Trial Profile
Placebo Controlled, Dose-Response, Randomized, Double Blind, Phase II Study to Evaluate the Efficacy and Safety of DA-6034 Eye Drops in Patients With Dry Eye Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Recoflavone (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 10 Sep 2014 New trial record